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MINI-FOCUS ISSUE: TRANSCATHETER INTERVENTIONS
CASE REPORT: CLINICAL CASE

Emergency Alcohol Septal Ablation for
Shock After TAVR
One More Option in the Toolbox
Mohammed Qintar, MD, MSC, Pedro Villablanca, MD, MSC, James Lee, MD, Dee Dee Wang, MD, Tiberio Frisoli, MD,
Brian O’Neill, MD, Marvin H. Eng, MD, William W. O’Neill, MD

ABSTRACT
We hereby report a case of severe shock from left ventricular outﬂow tract obstruction following transcatheter aortic
valve replacement that did not respond to medical therapy and had to be treated with emergent alcohol septal ablation
(ASA). Emergent ASA should be considered for bail-out treatment for these refractory cases. (Level of Difﬁculty:
Advanced.) (J Am Coll Cardiol Case Rep 2021;3:853–8) © 2021 The Authors. Published by Elsevier on behalf of
the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).

HISTORY OF PRESENTATION

tion to her right coronary artery, hypertension,
hyperlipidemia, and obstructive sleep apnea on home

A 74-year-old female patient was referred to our

continuous positive airway pressure.

hospital for evaluation of worsening dyspnea on
exertion. Her physical examination showed a grade 4/

DIFFERENTIAL DIAGNOSIS

6 systolic ejection murmur with absent S2.

PAST MEDICAL HISTORY
The patient has a medical history of coronary artery
disease with prior percutaneous coronary interven-

Severe

aortic

stenosis

and

hypertrophic

cardiomyopathy.

INVESTIGATIONS
Her echocardiogram was poor quality secondary to

LEARNING OBJECTIVES
 LVOTO or suicide left ventricle should be in
the differential for severe shock after TAVR.
 If medical treatment with ﬂuids, betablockers, and phenylephrine is not effective, emergent echo-guided ASA should be
considered.

her body habitus, but showed normal left ventricular
ejection fraction, calciﬁed and severely restricted
aortic valve, asymmetric upper septal hypertrophy
(Figure 1) with mild left ventricular outﬂow tract
(LVOT)

obstruction

(intracavitary

gradient

of

23 mm Hg, no provocation with Valsalva on echocardiogram), and severe aortic stenosis parameters.
Because of the poor quality of her echocardiogram,
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ABBREVIATIONS

further hemodynamic evaluation with inva-

hemodynamic assessment revealed peak-to-peak left

AND ACRONYMS

sive catheterization was performed. Just

ventricular-aortic gradient of 60 mm Hg with positive

below the aortic valve, the peak-to-peak

Brockenbrough sign and an increased gradient to

ASA = alcohol septal ablation
LVOT = left ventricular outﬂow
tract

LVOTO = left ventricular
outﬂow tract obstruction

TAVR = transcatheter aortic
valve replacement

gradient was 56 mm Hg and mean gradient

120 mm Hg (Figures 2C and 2D) compatible with

of 34 mm Hg with calculated aortic valve area

LVOTO or suicide left ventricle. Aggressive medical

of 0.42 cm2 . There was no intracavitary

therapy was initiated with ﬂuids, beta-blockers, and

gradient on the day of the invasive cathe-

phenylephrine without any success. Because of

terization study.

continuous decline in the patient’s clinical status, the
decision was made to pursue emergent alcohol septal

MANAGEMENT

ablation (ASA). A 6-F JL4 guide was engaged in the

The patient was referred for transfemoral transcatheter aortic valve replacement (TAVR). Intraprocedurally, very similar hemodynamic gradients
were

recorded

with

peak-to-peak

gradient

of

58 mm Hg and mean gradient of 35 mm Hg
(Figure 2A). Transfemoral TAVR was conducted as
usual, and after deployment of the 23-mm Edwards
Sapien valve, the recorded gradient was eliminated
(Figure 2B); however, the patient became hypotensive
and started complaining of severe chest pain and
shortness of breath. Prompt evaluation (included
aortogram, peripheral angiogram, and an emergency
echocardiogram) revealed no coronary obstruction,

left main and the ﬁrst septal perforator was mapped
(with live echocardiography guidance) to the asymmetric basal septum and then was injected with 1 mL
isopropyl alcohol (Figure 3) guided by bedside transthoracic

echocardiogram

(Figure

4).

Subsequent

angiography revealed occlusion of the injected septal
perforator. Repeat hemodynamic assessment after
ASA showed resolution of LVOTO, a negative Brockenbrough sign (Figure 2E), normalization of blood
pressure, and resolution of symptoms. The patient
was monitored in the intensive care unit for 1 night
and was discharged on post-operative day 3.

FOLLOW-UP

cardiac tamponade, severe paravalvular leak, or access site bleeding. The transthoracic echocardiogram,

Follow-up echocardiogram revealed LVOT gradient

albeit with poor windows secondary to body habitus,

of 25 mm Hg without any provocation. No atrio-

showed LVOT obstruction (LVOTO) and systolic

ventricular block was seen post-operatively or at

anterior

follow-up.

motion

of

the

mitral

valve.

Further

F I G U R E 1 Baseline Thoracic Echocardiogram and CT

(A) Echocardiogram (difﬁcult quality) shows mild asymmetrical hypertrophy in the basal septum. (B) CT transcatheter aortic valve replacement showing asymmetrical
hypertrophy in the basal septum. (C) Pulsed-wave Doppler showing mild baseline left ventricular outﬂow tract obstruction (23 mm Hg) without provocation and (D)
continuous-wave Doppler showing severe aortic stenosis (paradoxical low-ﬂow low-gradient). CT ¼ computed tomography.
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F I G U R E 2 Hemodynamic Tracings

Continued on the next page
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F I G U R E 2 Continued

(A) Hemodynamic tracing of the left ventricle-aorta (LV-AO) at baseline before transcatheter aortic valve replacement (TAVR) and placing the
pigtail catheter just below the valve to avoid contamination with the left ventricular outﬂow tract (LVOT) gradient. This tracing conﬁrms
diagnosis of severe low-ﬂow low-gradient aortic stenosis. (B) Hemodynamic tracing of the LV-AO after TAVR and placing the pigtail catheter
just below the valve to avoid contamination with the LVOT gradient showing successful TAVR and elimination of the severe aortic stenosis
gradient. (C) Hemodynamic tracing of the LV-AO placing the pigtail catheter inside the left ventricular cavity showing LVOT obstruction
(LVOTO). The ﬁfth measurement demonstrates the Brockenbrough sign with increased gradient after a premature ventricular contraction. (D)
Pull back of the pigtail catheter from the inside the left ventricular cavity to just below the aortic valve conﬁrming severe LVOTO. (E) Hemodynamic tracing of the LV-AO after alcohol septal ablation (ASA) showing successful elimination of the LVOTO and no gradient. Also
showing a negative Brockenbrough sign (which was positive before the ASA).
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F I G U R E 3 Intraprocedural Coronary Angiogram Showing the Emergent ASA Procedure

(A) Right anterior oblique projection showing the septal perforator. (B) Injection of the ﬁrst septal perforator while through an occlusive over the wire balloon. (C) Post
injection of alcohol showing successful ablation. ASA ¼ alcohol septal ablation.

DISCUSSION
F I G U R E 4 Intraprocedural Echocardiogram Showing Mapping of the First Septal to

Aortic stenosis causes hypertrophy of the left ventricle
that is often the cause of increased afterload and is
concentric in most cases. However, eccentric asymmetrical hypertrophy sometimes coexists with severe
aortic stenosis (1) and can pose a treatment challenge
when the afterload is suddenly relieved by means of
aortic valve replacement. The explanation for the
sudden shock after implantation of the valve is related
to the immediate reduction of the ﬁxed afterload and
the resulting acceleration of blood in the LVOT area.
Medical therapy is often successful in relieving the
obstruction, but reports of concomitant surgical
myectomy at time of surgical aortic valve replacement
for these cases has been reported (2). It is important for
TAVR operators to be aware of this serious condition
(suicide left ventricle) and be familiar with medical
therapy as well as transcatheter treatment options
(Central Illustration). Perhaps in patients with high
likelihood of shock from LVOTO, surgery can be
considered as an alternative for operable patients.
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C E NT R AL IL L U STR AT IO N Algorithm for Treating Patients With Severe Aortic Stenosis At High Risk for LVOT
Obstruction

Qintar, M. et al. J Am Coll Cardiol Case Rep. 2021;3(6):853–8.
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